Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation

A1 Journal article (refereed)


Internal Authors/Editors


Publication Details

List of Authors: Zhong BH, Strnad P, Toivola DM, Tao GZ, Ji XH, Greenberg HB, Omary MB
Publisher: AMER SOC CELL BIOLOGY
Publication year: 2007
Journal: Molecular biology of the cell
Journal acronym: MOL BIOL CELL
Volume number: 18
Start page: 4969
End page: 4978
Number of pages: 10
ISSN: 1059-1524


Abstract

The major keratins in the pancreas and liver are keratins 8 and 18 (K8/K18), but their function seemingly differs in that liver K8/K18 are essential cytoprotective proteins, whereas pancreatic K8/K18 are dispensable. This functional dichotomy raises the hypothesis that K8-null pancreata may undergo compensatory cytoprotective gene expression. We tested this hypothesis by comparing the gene expression profile in pancreata of wild-type and K8-null mice. Most prominent among the up-regulated genes in K8-null pancreas was mRNA for regenerating islet-derived (Reg)-II, which was confirmed by quantitative reverse transcription-polymerase chain reaction and by an anti-Reg-II peptide antibody we generated. Both K8-null and wild-type mice express Reg-II predominantly in acinar cells as determined by in situ hybridization and immunostaining. Analysis of Reg-II expression in various keratin-related transgenic mouse models showed that its induction also occurs in response to keratin cytoplasmic filament collapse, absence, or ablation of K18 Ser52 but not Ser33 phosphorylation via Ser-to-Ala mutation, which represent situations associated with predisposition to liver but not pancreatic injury. In wild-type mice, Reg-II is markedly up-regulated in two established pancreatitis models in response to injury and during the recovery phase. Thus, Reg-II is a likely mouse exocrine pancreas cytoprotective candidate protein whose expression is regulated by keratin filament organization and phosphorylation.

Last updated on 2019-18-07 at 06:53